DAPSONE
- Product NDC
- 10135-654
- 11-digit product format
- 101350654
- Labeler code
- 10135
- Product ID
- 10135-654_afbef0ba-7481-405d-9219-62ec25d9a618
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dapsone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals Inc
- Application
- ANDA206505
- Marketing category
- ANDA
- Marketing start
- 2018-05-01
- Marketing end
- 0000-00-00
- Substance
- DAPSONE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Sulfone [EPC],Sulfones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-654-01 | DAPSONE | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
| 10135-654-30 | DAPSONE | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-654 | DAPSONE TABLET [MARLEX PHARMACEUTICALS INC] | 1 | Legacy NDC, 2 package rows | 20180501_6c2159ce-5ef2-418c-bb14-e58f55438f80.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 10135-654-01 | 10135065401 | 100 in 1 BOTTLE | Historical |
| 10135-654-30 | 10135065430 | 30 in 1 BOTTLE | Historical |